ROAD appointed to promote antibiotic resistance “breakthrough”
Helperby Therapeutics has appointed healthcare comms specialist ROAD to help communicate its new solution, which could herald a breakthrough in the fight against microbial antibiotic resistance.
The agency will launch offline, digital and social media programmes to engage the medical and investment communities in conversation around “antibiotic resistance”.
“There has been no new class of antibiotic produced for over 30 years,” said Frances Crewdson, Helperby’s COO. “This new lease of life for antibiotics has the potential to help sustain our defence against life threatening superbugs for years to come.”
- Pictured: Frances Crewdson